Millstone Evans Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Millstone Evans Group's LLY Position: Q1 2026 in Review
Millstone Evans Group increased its Eli Lilly (LLY) stake by 5.8% in Q1 2026, buying an estimated $64.9K and bringing the position to 1,165 shares worth $1.07M. The position accounts for 0.64% of the portfolio, ranked #28.
Millstone Evans Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.18M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Millstone Evans Group held 1,165 shares of Eli Lilly worth $1.07M as of Q1 2026.
- Millstone Evans Group bought 64 Eli Lilly shares in Q1 2026, an estimated $64.9K.
- Eli Lilly made up 0.64% of Millstone Evans Group's portfolio in Q1 2026, its #28 holding.
- Millstone Evans Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Millstone Evans Group's Eli Lilly position peaked at $1.18M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Millstone Evans Group's 13F filing for Q1 2026, filed 30 Apr 2026.